Articles from Caixin Global, Caixin Global

Caixin Global

Articles from Caixin Global

Caixin is a media group dedicated to providing financial and business news through periodicals, online content, mobile apps, conferences, books and TV/video programs. Caixin aims to blaze a trail that helps traditional media prosper in the new media age through integrated multimedia platforms.

News from Caixin

Equity Bottom-Up

Northeast Pharmaceutical A / Equity Bottom-Up

<ul><li>Leading Chinese drug-ingredients supplier Northeast Pharmaceutical Group Co. Ltd. was fined 133 million yuan ($19 million) for abusing its dominant market position in materials used to make a treatment for kidney dialysis patients.</li><li>The market regulator in northeastern China’s Liaoning province conducted a three-year investigation of Northeast Pharmaceutical’s monopoly in the market for ingredients to make levocarnitine.</li><li>The medicine is used to treat dialysis patients for a lack of carnitine, a substance that helps the body convert fat into energy</li></ul>

Leading Chinese drug-ingredients supplier Northeast Pharmaceutical Group Co. Ltd. was fined 133 million yuan ($19 million) for abusing its dominant market position in materials used to make a treatment for kidney dialysis patients.The market regulator in northeastern China’s Liaoning province conducted a three-year investigation of Northeast Pharmaceutical’s monopoly in the market for ingredients to make levocarnitine.The medicine is used to treat dialysis patients for a lack of carnitine, a substance that helps the body convert fat into energy

Northeast Pharmaceutical Fined $19 Million for Jacking Up Drug Ingredient Prices

Cross Asset Strategy

<ul>
<li>Funds /: How China’s investment funds fared in 2022</li>
<li>China-U.S. /: China threatens retaliation after U.S. sanctions Chinese firms with alleged Russia ties</li>
<li>Li Yining /: Li Yining, who helped bring private investment to China’s state sector, dies at 92</li>
</ul>


Funds /: How China’s investment funds fared in 2022
China-U.S. /: China threatens retaliation after U.S. sanctions Chinese firms with alleged Russia ties
Li Yining /: Li Yining, who helped bring private investment to China’s state sector, dies at 92


CX Daily: China Threatens Retaliation After U.S. Sanctions Chinese Firms With Alleged Russia Ties

China

Northeast Pharmaceutical Group Co., Ltd. develops and manufactures biochemical products, pharmaceuticals, and other related products.  Through its subsidiaries, the Company also operates in commercial trading.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Northeast Pharmaceutical A (000597 CH)

Northeast Pharmaceutical Fined $19 Million for Jacking Up Drug Ingredient Prices

Leading Chinese drug-ingredients supplier Northeast Pharmaceutical Group Co. Ltd. was fined 133 million yuan ($19 million) for abusing its...

Caixin Global

CX Daily: China Threatens Retaliation After U.S. Sanctions Chinese Firms With Alleged Russia Ties

Funds /: How China’s investment funds fared in 2022 China-U.S. /: China threatens retaliation after U.S. sanctions Chinese firms with alleged...

Caixin Global

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)